An introduction to competing risks analysis

摘要: The need to develop treatments and/or programs specific a disease requires the analysis of outcomes be that disease. Such endpoints as heart failure, death due disease, or control local in cancer may become impossible observe prior occurrence different type event (such from another cause). which hinders changes possibility observing interest is called competing risk. usual techniques for time-to-event applied presence risks give biased uninterpretable results. estimation probability therefore needs calculated using such cumulative incidence function introduced by Kalbfleisch and Prentice. model Fine Gray can test covariate when are present. Using will ensure results unbiased correctly interpreted. Full English text available from: www.revespcardiol.org.